Results 161 to 170 of about 24,438 (192)

Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis

Journal of Clinical Apheresis, 2023
Lihong Yan
exaly  

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study

Therapeutic Apheresis and Dialysis, 2023
Katsuichi Miyamoto, Youwei Lin
exaly  

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease

British Journal of Clinical Pharmacology, 2013
Melanie White-Koning, Florent Puisset, Pr Lionel Rostaing   +2 more
exaly  

Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial

Intensive Care Medicine, 2002
Eduard Nedashkovsky
exaly  

[Plasmapheresis].

La Revue du praticien, 1973
M, Gaiffe, C, Scholtès
openaire   +3 more sources

PLASMAPHERESIS IN TREATMENT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED MYELOPATHY

Lancet, The, 1988
Shigenobu Nagataki, Hidenori Matsuo, Kohji Shibayama   +2 more
exaly  

Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report

Journal of Clinical Apheresis, 2004
Guvenc B, Emel Gurkan
exaly  

Plasmapheresis Reduces Proteinuria and Serum Capacity to Injure Glomeruli in Patients With Recurrent Focal Glomerulosclerosis

American Journal of Kidney Diseases, 1994
Virginia Savin, F Vincenti
exaly  

Plasmapheresis as treatment for hyperlipidemic pancreatitis

European Journal of Internal Medicine, 2014
Pedro Valdivielso
exaly  

Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial

International Immunopharmacology, 2023
exaly